Uncategorized Archives - Page 59 of 87 - PsychedelicNewsWire (PNW)

TuesdaySep 22, 2020 4:29 pm

Survey Shows Increased Dutch Interest in Psychedelics During Pandemic

In the Netherlands, the coronavirus pandemic and resulting lockdown significantly decreased drug use, particularly the use of ecstasy and cocaine. Its capital, Amsterdam, recorded the biggest decrease. The government-imposed restrictions that resulted in the closing of restaurants, cafes and clubs on March 15 led to home confinement for a majority of people. This presented a unique situation for researchers to measure drug use without the presence of an active night life or tourism in the society. The KWR Water Research Institute conducted an analysis of waste water in Amsterdam, Eindhoven and Utrecht between March 18 and 24 this year. The…

MondaySep 21, 2020 3:15 pm

Psychedelic Treatments: Bringing Out the Truth

In a discussion with Charles Raison, Psych Congress co-chair and professor at the University of Wisconsin-Madison, Penn., psychedelics, when used as treatments were more than just finding another way to reduce a disease’s symptoms. Andrew D. Penn is also a Psych Congress member and an associate clinical professor at the University of California. He explains that psychedelics would redefine psychiatry as the substances focused on healing. The field of psychiatry has tried to find a means to cure people, without success. Instead, the field has succeeded in reducing or rather, managing symptoms, which is not necessarily a bad thing. It…

MondaySep 21, 2020 1:14 pm

Pure Extract Technologies Inc. Sets Sights on Functional Mushroom Industry

Pure Extract Technologies focuses on extraction of volatile plant molecules Company has recently announced entry into functional mushroom market, providing extraction services Pure Extract applying for Natural Health Products site license with Health Canada, which will help ensure that high quality standards will be upheld while also lending Company sales entry into foreign markets Company is set to focus on development of tinctures, soft-gel products, followed by move into creating beverage formulations as well as oral and nasal sprays Pure Extract Technologies, (“Pure Extracts”) a Pemberton, British Columbia-domiciled private plant extraction company, has a successful history as the supplier of…

FridaySep 18, 2020 3:00 pm

Want to Learn More About the Psychedelic Experience? Read These Books!

With the many studies being conducted on the potential benefits that psychedelic substances may offer to humans as well as the up and coming psychedelic companies, psychedelics are going mainstream, and you must be having lots of questions about these substances. To educate yourself more on the spiritual and therapeutic potential of psychedelics, below are a few must-read psychedelic works that cover a range of related subjects with details on various clinical studies that have been done over the years. Drugged by Richard J Miller Richard J Miller, a Northwestern pharmacology professor, was first introduced to psychedelics while attending Woodstock,…

FridaySep 18, 2020 12:54 pm

Cybin Corp. New CEO Set to Pave Path to Profitability, Grow IP Portfolio Organically

Cybin announces appointment of established pharma industry figure as new CEO Drysdale leverages 30 years of leadership, entrepreneurial experience in life-science space Announcement comes as Cybin sets out on path to profitability Cybin Corp., an innovative life science company developing mushroom-derived psychedelic pharmaceuticals and nonpsychedelic nutraceutical products, has announced the appointment of Mr. Doug Drysdale as the company’s Chief Executive Officer. With more than three decades of experience, the new leader recognizes psychedelics as a major breakthrough in treating mental health conditions. Drysdale joins Cybin to pave the road for the company’s rapid growth, underpinned by the recent strong push…

ThursdaySep 17, 2020 3:45 pm

UC Berkeley Center for Psychedelics Research and Education to Launch Soon

The University of California, Berkeley announced yesterday their plans to launch a new center that will be dedicated to psychedelics research and education. According to a press release, researchers at the facility will use psychedelic substances to study cognition, emotion and perception and their biological behavior bases in the human brain. The new facility will also be putting resources into ensuring that the public is informed about this field of research that is rapidly advancing. The UC Berkeley Center for the Science of Psychedelics will begin its studies with psilocybin, which is a psychedelic compound that is found in magic…

WednesdaySep 16, 2020 3:30 pm

The History of Psychedelic Medicine

Psychedelic substances have been used by various indigenous communities for both therapeutic and community purposes for many centuries. They have been used in various communities in different ways such as in initiations, rites of passage or for other personal, social and healing works. As we all know, the European colonizers relied on tactics and strategies that were built on breaking and disrespecting beliefs of different peoples and massacring cultures as a whole, in an attempt to ‘civilize’ them. The arrival of colonizers in the South and North American continents began the demonization of psychedelic substances and as a whole, the…

WednesdaySep 16, 2020 3:03 pm

Cybin Corp. Leads Out in Growing Billion-Dollar Nutraceutical, Psychedelic Markets

Global nutraceutical market valued at $ 382.51 billion; psychedelic drugs market to reach $6.85 billion Cybin deploys two-pronged approach covering both psychedelic pharmaceutical and nutraceutical segments As psilocybin continues to prove effective in treating mental health conditions, the company is poised to leverage vast addressable market Cybin Corp., a Canadian early-stage life sciences company appears ideally positioned in two promising markets: nutraceuticals and psychedelic drugs. Both sectors are projected to see impressive growth in the coming years. Cybin looks to benefit from its growing footprint in both spaces. In 2019, the global nutraceutical market was valued at $382.51 billion. The…

WednesdaySep 16, 2020 12:59 pm

Pure Extract Technologies Inc. Building Presence in Billion-Dollar Mushroom Space

“Mushrooms are having a moment,” reports “Forbes” article Sector projected to benefit from both users, investors Pure Extracts Technologies well positioned to partner with organizations eyeing development in both functional, psychedelic products In what “Forbes” magazine is calling a “moment,” mushrooms are seeing rising popularity as growing numbers of people are interested in using the fungi as well as investing in them. This is great news for companies such as Pure Extract Technologies (“Pure Extracts”), a Canadian plant-based extraction company entering the functional medicinal mushroom space and collaborating in the psychedelic space “Psychedelics have been a mainstay for a millennia…

TuesdaySep 15, 2020 3:37 pm

New Study to Assess Psychedelics as Treatment for PTSD in Veterans

Recently, NeuroPharm Inc., a developer for psychedelic-based treatments announced that they would be collaborating with the Netherlands Leiden University Medical Center, on clinical trials centered on the treatment of PTSD in veterans. Psilocybin will be the first compound that will be studied. For those who may not have heard of psilocybin, it is a psychedelic substance found in about 200 mushroom species. This trial will involve 3 doses administered over a 12-week period and is said to be the first of its kind. Dr. Rakesh Jetly, NeuroPharm’s scientific advisor, explained that the trial primarily focused on veterans as PTSD impacted…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized